Drug Delivery Devices Market to Reach US$ 698.2 Bn by 2031, Growing at 7.4% CAGR as Smart and Wearable Devices Expand: New Report by Wissen Research

SHERIDAN, Wyo., Oct. 6, 2026 /PRNewswire/ -- The global drug delivery devices market is projected to grow from USD 488.6 billion in 2026 to USD 698.2 billion by 2031, registering a CAGR of 7.4% during the forecast period (2026–2031), according to a new study by Wissen Research.

Growth is being driven by rising prevalence of diabetes, respiratory disease, cancer, and other chronic conditions requiring continuous treatment, alongside growing use of biologics and peptide-based therapies that demand specialized administration systems. Expanding adoption of home healthcare and self-administration, combined with the rise of connected, smart drug delivery platforms, is reshaping how patients manage long-term treatment outside clinical settings.

Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=drug-delivery-device-market 

Where the Technology Is Heading: Connected Devices and Wearable Delivery

Drug delivery devices are moving beyond their original role of simply dispensing a fixed dose. The integration of sensors, digital interfaces, and connected software is turning injectors, inhalers, and infusion devices into platforms that can track missed doses, remind patients when treatment is due, and feed adherence data back to clinicians, capabilities that were largely unavailable when patients managed chronic conditions at home without any digital oversight.

Alongside this, wearable and on-body drug delivery systems are expanding rapidly, particularly for biologic therapies that require larger-volume doses or extended administration than a conventional syringe can practically support. On-body injectors, wearable infusers, and autonomous infusion systems are already established in diabetes care, immunotherapy, and oncology, and the growing pipeline of specialized biologics is creating demand for delivery systems built specifically around their administration requirements.

What's Fueling Growth in the Drug Delivery Devices Market

• Rising Chronic Disease Burden: Growing prevalence of diabetes, cardiovascular disease, and respiratory illness is increasing reliance on devices that support continuous, long-term treatment.
• Biologics and Complex Therapeutics: Rising use of biologics, peptides, and other complex medications is creating demand for specialized injectable and wearable delivery systems.
• Home Healthcare Expansion: Growing preference for self-administered treatment is increasing demand for simple, portable, and user-friendly devices.
• Smart and Connected Devices: Rising focus on treatment adherence and accurate dosing is driving development of connected, sensor-enabled delivery devices.
• Minimally Invasive Delivery Technology: Advances in targeted and minimally invasive drug administration are supporting development of more sophisticated delivery systems.
• GLP-1 and Injector Pen Demand: Surging demand for GLP-1 therapies for diabetes and weight management is driving substantial growth in injector pen and prefilled syringe volumes.

Challenges Facing the Drug Delivery Devices Market

Developing advanced delivery systems such as connected platforms, automated infusion systems, and wearable injectors requires substantial investment, a barrier that can be difficult for smaller manufacturers and healthcare companies to absorb. Pharmaceutical formulations must also be compatible with the delivery system itself, which adds complexity for specialized formulations and biologics, and device usability combined with the need for adequate patient training presents a further hurdle even as new technologies help address some of these issues.

Technical factors such as drug stability, viscosity, dosing requirements, and device reliability can create operational complications, while varied regulatory requirements across combination products, clinical trials, and manufacturing quality standards can substantially extend development timelines. Reimbursement structures and country-specific healthcare system constraints can also limit market access in certain regions.

Recent Strategic Developments in thewearable 

In September 2026, Medtronic's MiniMed division advanced its drug delivery portfolio with an FDA submission for the MiniMed Fit patch pump and CE Mark approval for MiniMed Flex, while progressing its next-generation extended-wear sensor and Vivera fully closed-loop insulin delivery system.

In August 2026, Linear Health Sciences partnered with Nipro Corporation to distribute the Orchid Safety Release Valve in Japan, a device designed to prevent IV catheter dislodgement by safely disconnecting infusion lines when excessive force is applied.

In July 2026, Becton, Dickinson and Company collaborated with EMS S.A. to launch semaglutide therapy in Brazil using BD's Vystra Injection Pen platform, combining pharmaceutical and device expertise to expand access to GLP-1 treatments.

These moves reflect an industry where device manufacturers, pharmaceutical companies, and regional distributors are increasingly partnering to expand access to GLP-1 and biologic therapies while strengthening safety and connectivity features across delivery platforms.

Key Insights from Drug Delivery Devices Market Analysis

• Inhalers led the market by product type in 2025, capturing approximately 24% share, driven by rising asthma and COPD prevalence and a series of industry mergers and acquisitions that expanded manufacturers' device capabilities.
• Diabetes held the largest share by application type in 2025, supported by an estimated 38.4 million people living with diabetes in the United States alone, sustaining strong demand for insulin pumps, pens, and continuous monitoring-integrated delivery systems.
• North America held the largest regional share in 2025, at roughly a third or more of global revenue, underpinned by advanced healthcare infrastructure, concentrated biologics R&D, and the world's highest per-capita spending on chronic disease management.
• Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising pharmaceutical production, and growing chronic disease prevalence across China, India, Japan, and South Korea.

Key Players in the Drug Delivery Devices Market

Leading companies in the drug delivery devices market are focused on innovation, strategic partnerships, and expansion of connected and wearable delivery platforms to strengthen their market position.

Regional Analysis and Growth Opportunities

North America leads the drug delivery devices market, supported by advanced healthcare infrastructure, concentrated biologics research and development, and the world's highest per-capita spending on chronic disease management. Rising GLP-1 therapy demand and continued investment in combination drug-device products, alongside a favorable regulatory environment, continue to reinforce the region's leading position.

Asia-Pacific is the fastest-growing region, propelled by rapidly developing healthcare infrastructure, growing pharmaceutical production, and rising chronic disease prevalence across China, India, Japan, and South Korea. Growing healthcare spending, expanding medical access, and increasing adoption of advanced pharmaceutical innovations continue to drive regional demand for injection, inhalation, and self-administration technologies.

Europe, Latin America, and the Middle East & Africa complete the report's regional coverage, with growth supported by expanding home healthcare adoption and rising biologics utilization.

Get a Custom Briefing on This Market for Your Business

Wissen Research's healthcare technology analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report 

Market Segmentation Snapshot

The global drug delivery devices market is segmented across product type, application type, end user, and region:

• By Product Type:
  • Inhalers (Metered-Dose Inhalers, Dry Powder Inhalers, Others)
  • Implants (Contraceptive Implants, Drug-Eluting Stents, Biodegradable Implants)
  • Injection Devices (Prefilled Syringes, Auto-Injectors, Pen Injectors, Needle-Free Injectors, Wearable Injectors)
  • Topical Delivery System (Creams, Gels, Ointments)
  • Oral Delivery System (Controlled-Release Tablets and Capsules, Buccal and Sublingual Tablets)
  • Ocular Delivery System
  • Nebulizers
  • Transdermal Patches
  • Infusion Pumps
• By Application Type:
  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Others
• By End User Type:
  • Hospitals
  • Diagnostic Centres
  • Ambulatory Surgery Centres/Clinics
  • Home Care Settings
  • Others
• By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Q: What is the size of the drug delivery devices market? 

A: The global drug delivery devices market is estimated at USD 488.6 billion in 2026 and is projected to reach USD 698.2 billion by 2031.

Q: What is the growth rate of the drug delivery devices market? 

A: The drug delivery devices market is projected to grow at a CAGR of 7.4% between 2026 and 2031.

Q: Which product segment leads the drug delivery devices market? 

A: Inhalers led the market by product type in 2025, capturing approximately 24% share, driven by rising asthma and COPD prevalence.

Q: Which application holds the largest share of the drug delivery devices market? 

A: Diabetes held the largest share by application type in 2025, supported by sustained demand for insulin pumps, pens, and continuous monitoring-integrated delivery systems.

Q: Which region leads the drug delivery devices market? 

A: North America held the largest share of the drug delivery devices market in 2025, while Asia-Pacific is the fastest-growing region through 2031.

Q: Who are the top players in the drug delivery devices market? 

A: Leading companies in the drug delivery devices market include Becton, Dickinson and Company, Medtronic plc, Baxter International Inc., West Pharmaceutical Services, Inc., and Gerresheimer AG.

As wearable and connected drug delivery platforms, biologics-specific administration systems, and GLP-1-driven injector pen demand continue to reshape the industry, drug delivery devices are becoming an increasingly central layer of chronic disease management and home-based healthcare. For manufacturers, the path forward lies in continued investment in device connectivity, biologics compatibility, and manufacturing capacity to meet rising global demand.

Get the Complete Drug Delivery Devices Market Report — Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/drug-delivery-device-market 

Expert Profile | Mayur Jain, Wissen Research 

Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry. 

Email: mayur@wissenresearch.com
LinkedIn:  https://www.linkedin.com/in/mayur-jain-0190542a/ 

About Wissen Research

Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets

Company Contact:

Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research